Abstract
1 Two double-blind, randomised studies were performed to compare the efficacy of fluvoxamine and chlorimipramine in depressed patients. In the first study the effects of a single daily dosage of between 100 and 300 mg of fluvoxamine were compared with those of chlorimipramine at a dosage of 50-150 mg daily in 43 out-patients with endogenous depression. 2 In a second study using three times daily dosing with a daily dosage of 150-300 mg for both fluvoxamine and chlorimipramine, 30 in-patients with unipolar depression were assessed. 3 Four weeks of treatment with single daily dosing resulted in a mean improvement of 61.4% (+/- s.d. 31.7) on the Hamilton Rating Scale for Depression (HAMD) for fluvoxamine and of 65.3% (+/- s.d. 25.8) for chlorimipramine. In the study with three times daily dosing the mean results were 72.9% (+/- s.d. 22.3) improvement for fluvoxamine and 62.1% (+/- s.d. 28.5) for chlorimipramine. 4 At similar dosages, fluvoxamine had significantly less untoward effects on blood pressure than chlorimipramine. Anticholinergic effects were also fewer in the fluvoxamine group, as were nervous system symptoms, with the latter difference reaching statistical significance (P = 0.02). 5 We conclude that fluvoxamine, given ...Continue Reading
References
Aug 1, 1977·British Journal of Pharmacology·V ClaassenP Placheta
Aug 1, 1974·Psychological Medicine·R A BraithwaiteR Gaind
Jan 1, 1972·Archives of General Psychiatry·J P FeighnerR Munoz
Dec 1, 1967·The British Journal of Social and Clinical Psychology·M Hamilton
Jul 1, 1981·Acta Psychiatrica Scandinavica·C J KlokD Doogan
Sep 1, 1982·Journal of Affective Disorders·J E De Wilde, D P Doogan
Jan 1, 1983·British Journal of Clinical Pharmacology·J D GuelfiP Pichot
Citations
Jan 1, 1992·Psychopharmacology·T BougerolH Mikkelsen
Mar 24, 2010·Psychopharmacology·Mizuho SekineTetsuya Suhara
Jan 1, 1990·Progress in Neuro-psychopharmacology & Biological Psychiatry·D RothD V Sheehan
Mar 1, 1993·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·S KasperH J Möller
Apr 13, 2000·Journal of Affective Disorders·I M Anderson
Nov 9, 2001·The International Journal of Neuroscience·Y KanedaT Ohmori
Jan 1, 1990·Current Medical Research and Opinion·G GonellaU Ecari
Jan 1, 1985·Current Medical Research and Opinion·U A SiddiquiD K Jesinger
Jan 7, 2015·The Journal of Toxicological Sciences·Yukiko Yamazaki-HashimotoAtsushi Sugiyama
Jan 1, 1983·British Journal of Clinical Pharmacology·J C Roos
Jan 1, 1989·Psychological Medicine. Monograph Supplement·S J WarringtonM Lader
Feb 18, 2005·International Journal of Geriatric Psychiatry·Maria Stella T GironBengt Winblad
Jan 1, 1994·Journal of Psychopharmacology·I M Anderson, B M Tomenson
Jul 20, 2007·The Cochrane Database of Systematic Reviews·J R GeddesJ Boynton
Jul 20, 2007·The Cochrane Database of Systematic Reviews·C BarbuiJ M Mason
Feb 1, 1997·The British Journal of Psychiatry : the Journal of Mental Science·M HotopfG Lewis
Mar 20, 2010·The Cochrane Database of Systematic Reviews·Ichiro M OmoriToshi A Furukawa
Dec 1, 1988·Acta Psychiatrica Scandinavica·W A NolenJ Haffmans